Telix Pharmaceuticals |
High $11.49 |
Low $11.20 |
Trades 4,718 |
Turnover $7,499,551 |
Volume 664,557 |
| 30 June 2023 at 4:12pm | ||||
|
Market Cap (14-Nov) $4,655,044,608 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (9-Nov) 35,408,995 (10.40%) (16th) |
|
52w High $18.22 |
52w Low $8.26 |
P/E 178.57 |
EPS 0.15 |
Appendix 4C and Activities Report - December 2022 Quarter
TLX released this announcement to the ASX on 18 January 2023, 8:27. The announcement is marked as price sensitive, and is 10 page(s) in length and 237.34kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 1.569% short sold according to ASIC data. It was ranked the 150th most shorted stock on the ASX. It is now ranked as the 16th most shorted stock on the ASX with 10.404% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Appendix 4C and Activities Report - December 2022 Quarter | 18 January 2023, 8:27 |
| Notification of upcoming quarterly results and investor call | 12 January 2023, 8:25 |
| Webcast link correction - JP Morgan Conference Presentation | 10 January 2023, 12:58 |
| Notification of cessation of securities - TLX | 9 January 2023, 8:26 |
If you were already registered, log in here.